Sight Sciences

Join us in welcoming Cherri James and Duane Thorpe to Sight Sciences and our Market Access team! A big thank you to Bobby Saenz, OD, for leading an insightful training session and our leaders for setting them up for success. Cherri and Duane, we are excited to have you join the team—get ready to transform eyecare together!

Meet our colleague Sage St. Clair, SHRM-CP! Sage’s journey at Sight Sciences is a testament to growth, collaboration, and perseverance, and she continues to make an impact every day. Here’s what Sage had to say about her experience at Sight Sciences: "Over the last four years at Sight Sciences, I’ve had the opportunity to collaborate cross-functionally with many departments and have enjoyed getting to work with and learn from everyone. From going through the IPO process in 2021 to the fast-paced environment we work in every day, Sight has always challenged me to grow in my career. I am grateful for my team and I am excited for what is next!" Thank you, Sage, for your dedication and passion! 👏 #EmployeeSpotlight #TeamSightSciences #LifeAtSightSciences

Glaucoma is a leading cause of irreversible blindness, but early detection can make all the difference. This World Glaucoma Week, we stand with the World Glaucoma Association and many others to raise awareness about the importance of regular eye exams and optic nerve checks. Let’s work together to protect sight and empower people with knowledge about this silent disease. #WorldGlaucomaWeek #GlaucomaAwareness #GlaucomaWeek  Source: www.worldglaucomaweek.org

Today, we celebrate all women, especially those working hard to shape the present and future of eyecare. Your leadership, expertise, and dedication drive innovation and improve patient outcomes every day. Thank you for all that you do. Happy International Women’s Day! 💜 #InternationalWomensDay #IWD2025 #WomenInEyecare #WomenInOphthalmology

Congratulations to Alyssa M. Darrah, MD, of The Eye Centers, on completing clinical and surgical training with the OMNI Surgical System! Your commitment to advancing glaucoma care and enhancing patient outcomes is truly commendable. 👏👏👏

Thank you for making AGS 2025 an exceptional and productive experience—perhaps our best yet. We appreciate you joining us for educational dinners, advisory board meetings, our symposium, booth discussions, and other key gatherings. Your insights and partnership are invaluable as we continue advancing eyecare through transformative technology and an interventional mindset. Thank you!

Will You Wait or Act? The Critical Choice in Combating Glaucoma. What an excellent symposium at #AGS2025! A big thank you to the 160+ attendees who joined us for this essential discussion on the state of MIGS and interventional glaucoma treatment. Special appreciation to Ike Ahmed, MD; Christine Funke, MD; Zarmeena Vendal, MD; and Reay Brown, MD, for sharing their invaluable insights on #glaucoma, #MIGS, and the unmet clinical needs in pseudophakic treatment.

Thomas W. Samuelson, MD (Thursday) and Nathan Radcliffe, MD (Friday) will be at our booth at #AGS2025! Stop by for a unique opportunity to ask questions and hear firsthand about their experience with the OMNI® Surgical System, the latest clinical data, and their approach to MIGS and interventional glaucoma. See you there! www.sightsciences.com/ags __________ This event is neither sponsored nor endorsed by the American Glaucoma Society. The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Visit omnisurgical.com/ifu for the indications for use, contraindications, warnings, and potential adverse events. The physicians are paid consultants of Sight Sciences.

#AGS2025 is almost here, and we look forward to seeing you in Washington, DC! Join us for peer-to-peer conversations on Thursday and Friday at our booth, three educational dinner programs on Thursday and Friday, a lunch symposium on Saturday, daily clinical presentations, and hands-on technology demonstrations. Don’t miss this opportunity to connect, learn, and explore the latest in eye care innovation. See you there! www.sightsciences.com/ags __________ The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Visit omnisurgical.com/ifu for the indications for use, contraindications, warnings, and potential adverse events. Ike Ahmed, MD; Jason Bacharach, MD; Matthew Brink, MD; Usha Bulusu, MD; Reay Brown, MD; Christine Funke, MD; Noureen Khan, MD; Nathan Radcliffe, MD; Thomas W. Samuelson, MD; Monisha Vora, MD; and Zarmeena Vendal, MD, are paid consultants of Sight Sciences.

Our annual Sight Sales Meeting was so much fun! What a fantastic team! A huge congratulations to our Circle of Sight and Sight Power Club winners! Your dedication, expertise, and passion for advancing eye care inspire us all. Thank you for your hard work and commitment to making a difference! ❤️👏 #SightSalesMeeting #SightSciencesTeam #SightSciences